Literature DB >> 9709883

Pneumonia after heart transplantation: a multi-institutional study. Spanish Transplantation Infection Study Group.

J M Cisneros1, P Muñoz, J Torre-Cisneros, M Gurgui, M J Rodriguez-Hernandez, J M Aguado, A Echaniz.   

Abstract

A multiinstitutional study of 307 heart transplant recipients was carried out to determine the clinical, radiographic, and prognostic characteristics, the incidence, and the etiology of pneumonias in the first year after transplantation. There were 21.1 cases of pneumonia per 100 heart transplantations. Seventy-five percent of the cases occurred in the first trimester. Eighty-two causal agents were identified, of which 60% were opportunistic, 25% were nosocomial, and 15% were community-acquired. The most frequent isolates were cytomegalovirus (20), Aspergillus species (13), and Pneumocystis carinii (11). Hemoptysis occurred more frequently in aspergillus pneumonias than in other pneumonias (54% vs. 6%, respectively; P < .05); aspergillus pneumonia was the only type of pneumonia during which cavitated nodules were noted on thoracic radiographs. The overall mortality rate was 30.8%; the independent factors of a poor prognosis were aspergillus infection (relative risk [RR], 7.4; 95% confidence interval [CI], 5.8-9.1) and bilateral pulmonary infiltrates (RR, 10; 95% CI, 8.5-11.4).

Entities:  

Mesh:

Year:  1998        PMID: 9709883     DOI: 10.1086/514649

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

Review 1.  A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host.

Authors:  C Mayaud; J Cadranel
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

Review 2.  Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.

Authors:  Michael D Duncan; David S Wilkes
Journal:  Proc Am Thorac Soc       Date:  2005

Review 3.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

4.  Sepsis in the severely immunocompromised patient.

Authors:  Andre C Kalil; Steven M Opal
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

5.  Outcomes of Pneumocystis jiroveci pneumonia infections in pediatric heart transplant recipients.

Authors:  Benton Ng; Anne Dipchand; David Naftel; Paolo Rusconi; Gerard Boyle; Theo Zaoutis; R Erik Edens
Journal:  Pediatr Transplant       Date:  2011-12

6.  Broad-spectrum antiherpes activities of 4-hydroxyquinoline carboxamides, a novel class of herpesvirus polymerase inhibitors.

Authors:  Nancee L Oien; Roger J Brideau; Todd A Hopkins; Janet L Wieber; Mary L Knechtel; John A Shelly; Robert A Anstadt; Peter A Wells; Roger A Poorman; Audris Huang; Vallerie A Vaillancourt; Terrance L Clayton; John A Tucker; Michael W Wathen
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 7.  High-resolution computed tomography (HRCT) of lung infections in non-AIDS immunocompromised patients.

Authors:  Tomás Franquet
Journal:  Eur Radiol       Date:  2005-10-14       Impact factor: 5.315

8.  Differentiation of C2D macrophage cells after adoptive transfer.

Authors:  Betsey E Potts; Marcia L Hart; Laura L Snyder; Dan Boyle; Derek A Mosier; Stephen K Chapes
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

9.  Late presentation of Pneumocystis jiroveci pneumonia after cardiac transplantation.

Authors:  L R Craker
Journal:  BMJ Case Rep       Date:  2010-10-22

10.  Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis.

Authors:  Adoración Navarro-Torné; Eva Agostina Montuori; Vasiliki Kossyvaki; Cristina Méndez
Journal:  Hum Vaccin Immunother       Date:  2021-06-09       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.